[Expression of macrophage migration inhibitory factor and CD74 in preeclamptic placenta and its correlation with preeclampsia]

Zhonghua Fu Chan Ke Za Zhi. 2010 Apr;45(4):278-82.
[Article in Chinese]

Abstract

Objective: To investigate the expression of macrophage migration inhibitory factor (MIF) and CD74, the receptor of MIF, in preeclamptic placenta and its correlation with the pathogenesis of preeclampsia.

Methods: From March 2008 to November 2008, 69 preeclamptic women who delivered in the Department of Obstetrics, Affiliated Hospital of Qingdao University Medical College, were recruited, including 33 women with mild preeclampsia (MPE group) and 36 women with severe preeclampsia (SPE group). Another 43 healthy pregnant women were taken as control group. Immunoturbidimetry was applied to measure the concentrations of C-reactive protein (CRP) in maternal blood. The expressions of MIF and CD74 in placenta were tested with immunohistochemistry and the expressions of MIF mRNA and CD74 mRNA were detected by semiquantitative RT-PCR. The relationship between maternal blood level of CRP and MIF mRNA and CD74 mRNA in placenta was analyzed in the MPE and SPE group.

Results: (1) MIF and CD74 were expressed in the placenta of all pregnant women in the 3 groups, as shown in brown-yellow color, and significantly higher expression was found in the MPE and SPE group. (2) The expression of MIF mRNA and CD74 mRNA in the MPE group (0.70+/-0.13 and 0.96+/-0.16), SPE group (0.88+/-0.12 and 1.08+/-0.15) were significantly higher than in the control group (0.67+/-0.11 and 0.83+/-0.14) (P<0.01), and statistical significance was also found between the MPE and SPE group (P<0.01). (3) The maternal blood concentrations of CRP in the MPE and SPE group were significantly higher than in the control group [(15.3+/-7.0) mg/L and (21.6+/-9.1) mg/L vs (4.8+/-1.8) mg/L, P<0.01], and significant difference was also found between the MPE and SPE group (P<0.01). (4) In the two preeclamptic groups, the blood concentrations of CRP were positively correlated with the expression of both MIF mRNA (r=0.67, P<0.01) and CD74 mRNA (r=0.83, P<0.01) in placenta. Positive correlation was also found between the levels of MIF mRNA and CD74 mRNA in placenta (r=0.93, P<0.01).

Conclusions: Overexpression of MIF and CD74 in the placenta may up-regulate the CRP level in maternal blood, resulting in systemic inflammatory reaction and vascular endothelium damage which may be involved in the pathogenesis of preeclampsia.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Antigens, Differentiation, B-Lymphocyte / genetics
  • Antigens, Differentiation, B-Lymphocyte / metabolism*
  • C-Reactive Protein / analysis
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / pathology
  • Female
  • Gestational Age
  • Histocompatibility Antigens Class II / genetics
  • Histocompatibility Antigens Class II / metabolism*
  • Humans
  • Immunohistochemistry
  • Intramolecular Oxidoreductases / genetics
  • Intramolecular Oxidoreductases / metabolism*
  • Macrophage Migration-Inhibitory Factors / genetics
  • Macrophage Migration-Inhibitory Factors / metabolism*
  • Placenta / metabolism*
  • Placenta / pathology
  • Pre-Eclampsia / etiology*
  • Pre-Eclampsia / metabolism
  • Pre-Eclampsia / pathology
  • Pregnancy
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Severity of Illness Index

Substances

  • Antigens, Differentiation, B-Lymphocyte
  • Histocompatibility Antigens Class II
  • Macrophage Migration-Inhibitory Factors
  • RNA, Messenger
  • invariant chain
  • C-Reactive Protein
  • Intramolecular Oxidoreductases
  • MIF protein, human